ARTICLE | Company News
Oryzon, Roche deal
May 30, 2016 7:00 AM UTC
Oryzon and Roche extended by one year until March 2017 a collaborative research program to explore the potential of ORY-1001 in cancer and hematology indications beyond acute leukemia. The research p...